Security key
M4119S187
Evogene Ltd. - Ordinary shares, par value NIS 0.20 per share (EVGN)
CUSIP: M4119S187
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary shares, par value NIS 0.20 per share
- Total 13F shares
- 181,682
- Total 13F value
- $199,835
- Share change
- +18,886
- SEC-reported price per share
- $1.10
- Number of holders
- 17
- Value change
- +$20,300
- Number of buys
- 4
- Number of sells
- 7
- Shares outstanding
- 18,048,926
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
17
Top holders
10
EVGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Evogene Ltd. SEC filings
Evogene Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M4119S187
Recent filing periods:
Ownership snapshot
Top reported holders of EVGN - Evogene Ltd. - Ordinary shares, par value NIS 0.20 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
CITADEL ADVISORS LLC
Comparable rows
0/13
Latest evidence
30 Sep 2025
13F
Highest disclosed value: $65,636
13 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
CITADEL ADVISORS LLC has the largest disclosed position value at $65.6K.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
CITADEL ADVISORS LLC
$65.6K
JANE STREET GROUP, LLC
$45K
MORGAN STANLEY
$34.7K
TWO SIGMA SECURITIES, LLC
$13K
BNP PARIBAS FINANCIAL MARKETS
$12.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$65,636
57,575 shares
|
— | 30 Sep 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$45,021
39,423 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$34,652
30,343 shares
|
— | 30 Sep 2025 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$13,026
11,406 shares
|
— | 30 Sep 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
—
denominator unverified
|
$12,826
11,231 shares
|
— | 30 Sep 2025 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$1,372
1,201 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
181,682
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
13
Q4 2025 holders
17
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend